Molecular Scaffolds as Double Targeting Agents for the Diagnosis and Treatment of Neuroblastoma.

Angewandte Chemie - International Edition - United Kingdom
doi 10.1002/anie.201811691
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

In-Silico Molecular Design of Heterocyclic Benzimidazole Scaffolds as Prospective Anticancer Agents

BMC Chemistry
Chemistry
2019English

Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2012English

Targeting mTOR for the Treatment of AML. New Agents and New Directions.

Oncotarget
Oncology
2011English

Genetic and Molecular Alterations in Olfactory Neuroblastoma: Implications for Pathogenesis, Prognosis and Treatment

Oncotarget
Oncology
2016English

Docosahexaenoic Acid Serving as Sensitizing Agents and Gefitinib Resistance Revertants in EGFR Targeting Treatment

OncoTargets and Therapy
OncologyPharmacology
2019English

Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Targeting Angiogenesis as Treatment for Obesity

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

Molecular Targeted Agents as Second-Line Treatment for Hepatocellular Carcinoma: A Meta-Analysis and Review

Oncotarget
Oncology
2017English

Table 2: Anti-Tumor Agents for Targeting Hypoxia-Induced CA IX for Therapy and Diagnosis.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy